title: [Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
abstract: The paper was performed in order to evaluate the influence of sulfinpyrazone given orally in the doses of 400 mg to 16 uraemic patients during intermittent peritoneal dialysis on transperitoneal and renal transfer of different molecular weight substances. It was shown that sulfinpyrazone causes the increase in dialysate excretion of uric acid, sodium and protein but does not influence the transperitoneal transfer of water, potassium, creatinine, glucose, heparin and acetic acid. Renal function determined by diuresis volume as well as clearance of sodium, potassium, creatinine, uric acid and protein remained unchanged after the drug administration. Thus, when sulfinpyrazone is used during peritoneal dialysis a possibility of its action on the peritoneal membrane permeability should be taken into consideration.
authors.affiliation: Kliniki Nefrologii Instytutu Chorób Wewnetrznych Akademii Medycznej im. K. Marcinkowskiego w Poznaniu.
authors.forename: A
authors.initials: A
authors.lastname: Grzegorzewska
authors.forename: K
authors.initials: K
authors.lastname: Antoniewicz
authors.forename: J
authors.initials: J
authors.lastname: Kuźniak
authors.forename: E
authors.initials: E
authors.lastname: Zawadzka
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects / Q000502:physiology; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000379:methods*; D011506:Proteins / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D014527:Uric Acid / Q000378:metabolism*
chemical_list: D011506:Proteins; D014527:Uric Acid; D012964:Sodium; D013442:Sulfinpyrazone
vernacular_title: Wpływ sulfinpyrazonu na oczyszczanie otrzewnowe i nerkowe u chorych z mocznica leczonych przerywana dializa otrzewnowa.